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Abstract
The genus Citrus belongs to family Rutaceae, which is characterized by trees and bushes. 
Citrus species are extensively cultivated throughout the world because of their multiple 
health benefits for humans and their applications in pharmaceutical and food industries. 
This chapter is a survey covering in vitro and in vivo studies that demonstrate the pharma‐
cological activities of various Citrus species. The species Citrus aurantium, Citrus sinensis, 
Citrus limon, and Citrus bergamia are well known and several studies have been carried 
out to evaluate the pharmacological effects of their extracts, essential oils, and isolated 
constituents. These studies have found that they possess anxiolytic, anti‐inflammatory, 
hypoglycemic, anthelmintic, anticancer, and anti‐infective properties.
Keywords: Citrus, Pharmacology, Citrus aurantium, Citrus sinensis, Citrus limon, Citrus 
bergamia
1. Introduction
The genus Citrus belongs to family Rutaceae, which is characterized by trees and bushes. 
Fruits of this genus, such as oranges, lemons, and tangerines, are widely cultivated in the 
tropical and subtropical areas of the world [1].
In medicine, Citrus fruits are used in the treatment of various diseases. Research shows 
that the intake of Citrus fruits can reduce the incidence of gastric cancer [2]. In addition, 
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some isolated compounds from these fruits have effects on the central nervous system. For 
example, limonene, which is present in high concentrations in Citrus aurantium, showed a 
strong anxiolytic effect when tested in both animals and humans [3, 4].
To further understand the therapeutic potential of different Citrus species, we carried out a 
survey of in vitro and in vivo studies demonstrating their pharmacological actions, and sum‐
marized them in this chapter.
2. Citrus species with pharmacological activity
2.1. Citrus aurantium L
The species C. aurantium L., popularly known as bitter orange, laranjeira‐amarga, or laranjeira‐
cavalo, is a native plant of Southeast Asia, a region that corresponds to China and India. It was 
first introduced to Syria and Egypt by the Arabs and was subsequently brought to Europe [1]. 
In the medieval times, it was widely used in the Mediterranean region as a cardiac and vascu‐
lar stimulant, digestive, sedative, tranquilizer, appetite stimulant, general tonic, and antidote 
against poisons [5]. In traditional Chinese medicine, bitter orange is used as a gastrointestinal 
stimulant and general tonic [6].
Ethnopharmacological studies in Brazilian communities (documentation of the empirical uses 
of medicinal plants in traditional communities) describe the popular use of C. aurantium L. 
fruit peels, flowers, and leaves in the treatment of the central nervous system disorders such 
as insomnia, anxiety, and hysteria [7, 8]. Another study reports that tea made from the leaves 
of C. aurantium L. can relieve stomach cramps and constipation, combat stomach acidity, and 
relieve fever, while tea from the seeds is reported to control diabetes [9].
Studies have focused on the investigation of C. aurantium L. effects on the central nervous 
system, especially its anxiolytic effect. Several studies on animals and humans have dem‐
onstrated the anxiolytic effect of this species. For example, the essential oil obtained from C. 
aurantium L. peels was found to show an anxiolytic effect on rats after a single dose, denoted 
by an increase in the residence time in the open arms of the elevated plus maze [10]. In addi‐
tion, anxiolytic activity was observed in experimental models of generalized anxiety and 
obsessive‐compulsive disorder. At the same time, the mice did not show any signs of motor 
impairment, even after 15 consecutive days of treatment [7].
In a study conducted by Leite et al., 12 rats were evaluated in two models of anxiety: elevated 
plus maze and open field maze models. The rats were previously made to inhale the essential 
oil from C. aurantium L. at concentrations of 1.0, 2.5, and 5.0% for 7 min in an acrylic box. The 
authors observed a decrease in the emotional reactivity of the animals in both experimen‐
tal models, suggesting a possible central action [11]. Moreover, the results of another study 
strongly suggest the involvement of 5‐HT 1a receptor, a subtype of serotonin receptors, in 
its anxiolytic activity, suggesting a potential mechanism by which C. aurantium L. affects the 
central nervous system [12].
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Clinical trials testing the anxiolytic effect of C. aurantium have also demonstrated satisfactory 
results. In a certain study, preoperative patients received distilled C. aurantium L. flower 2 h 
before the procedure, then the STAI scale was used for anxiety evaluation. In comparison to 
the control group, the patients from experimental group showed a reduction in preoperative 
anxiety [13]. In another study, patients with chronic myelogenous leukemia inhaled essential 
oil of C. aurantium L. before the procedure of medullary material collection. The results indi‐
cated that the patients subjected to this intervention showed a decrease in the anxiety levels 
and remained relaxed during the procedure. In addition, C. aurantium L. oil, even at a single 
exposure, showed an activity comparable to that of the anxiolytic used as the positive control. 
This ensures its efficacy in controlling anxiety in patients subjected to unpleasant diagnostic 
procedures [3].
Its anxiolytic effect was also tested before labor. In a certain study, 18–35‐year‐old primipa‐
rous women were subjected to aromatherapy with C. aurantium L. oil during labor, and the 
results showed a significant reduction in the anxiety during labor in those women. Another 
clinical trial conducted on 126 primiparous women investigated the effects of aromatherapy 
with C. aurantium L. on pain during the first stage of labor. The women received 4 ml of 
C. aurantium L. in distilled water soaked in gauzes every 30 min. The results showed pain 
relief in the women subjected to this procedure. When asked whether aromatherapy using 
C. aurantium L. was satisfactory or not, 88.1% of the participants said that they were satisfied 
with the method applied and 92.1% said that they would use this method in future pro‐
cedures. These studies show that aromatherapy with C. aurantium L. is a simple, inexpen‐
sive, and noninvasive intervention that can be beneficial for pregnant women [14]. However, 
because vaginal birth is a painful and serious process that is often feared by primiparous 
women, further studies are still required [15].
Several studies have been conducted to identify other possible actions of C. aurantium L. 
constituents, other than their effects on the central nervous system. Researchers isolated the 
flavonoids such as nobiletin, naringin, and hesperidin from C. aurantium L. and evaluated 
their anti‐inflammatory effect on rat cells in vitro. Results demonstrated the suppression of 
proinflammatory mediators, which confirms the anti‐inflammatory action of the isolated 
flavonoids [16]. Flavonoids isolated from C. aurantium L. were also evaluated for possible 
anticancer activity in murine lung cells. They demonstrated an anticancer effect through the 
regulation of apoptosis and cell migration, providing scientific support for the use of C. auran‐
tium L. flavonoids in the treatment of human lung cancer [17].
Using a rat model of diabetes, researchers evaluated the possible hypoglycemic effect of neo‐
hesperidin derived from C. aurantium L. Treatment with neohesperidin was shown to increase 
glucose tolerance and insulin sensitivity, and to decrease blood glucose levels in the rats of the 
experimental group. These results demonstrate its hypoglycemic effect, and thus, its potential 
application for the prevention of diabetes and its complications [18].
Finally, although C. aurantium L. has been known for millennia, and a large number of studies 
have been focusing on its effects in the last decade, further research is needed to elucidate new 
mechanisms of action and therapeutic properties.
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2.2. Citrus sinensis
The species C. sinensis, popularly known as sweet orange, also belongs to family Rutaceae. 
This fruit is of Asian origin, where it has been known for about 4000 years. With the expan‐
sion of trade and shipping routes, orange was introduced to various regions of the world for 
cultivation. Information from 1471 to 1472 reported the presence of sweet orange in Liguria, 
a region in Italy, before its introduction by the Portuguese to the Iberian Peninsula in 1498. In 
the eighteenth century, there were reports about varieties of sweet orange in Palestine, pos‐
sibly introduced by an Armenian monk. In the Americas, Portuguese colonists introduced it 
to Bahia/BR in the sixteenth and eighteenth centuries, and Jesuits introduced it to California/
USA, where they settled and started subsequent plantations [19].
An ethnobotanical survey in a Brazilian community identified the species C. sinensis as the 
most cited by women in attention to basic health, indicating the use of its leaves prepared in 
the form of tea as a soft tranquilizer for mild cases of anxiety and insomnia [20]. In addition, 
the flower and fruit are used by the population as tranquilizers and for relief of headache, 
migraine, fever, flu, allergy, and cough. We can conclude that sweet orange is among the main 
species of medicinal plants commonly used by the Brazilian community [21].
The traditional use of C. sinensis as a sedative can be attributed to hesperidin, which was 
identified in a study as the active principle in this plant responsible for sedation. Hesperidin 
performs its sedative action through interaction with and stimulation of adenosine receptors. 
Its effect is opposite to that observed after consumption of coffee and tea, which antagonize 
the adenosine receptors and thus maintain the wakefulness state [22]. Researchers investi‐
gated the properties of hesperidin extracted from C. sinensis through in vitro experiments, 
revealing its strong cytotoxic activity against human carcinoma cell lines and its antioxidant 
activity against DPPH free radical. According to these results, hesperidin can be considered a 
promising future drug. Orange peels are a cheap and available source from which hesperidin 
can be extracted in an efficient way and with high purity [23].
C. sinensis extracts have shown potent anthelmintic properties in vitro when compared with 
the positive control, indicating that it is equipotent to conventional anthelmintic drugs. 
However, in vivo studies should be conducted to establish this efficacy and to identify the 
active components responsible for the anthelmintic activity [24].
Researchers induced liver cirrhosis in rats for 16 weeks and treated the animals with C. sinensis 
dried peel extract orally for 9 weeks. After the completion of the treatment, the animals were 
euthanized to evaluate the biochemical and histopathological changes associated with liver 
cirrhosis. The histopathological examination of the liver tissue and the biochemical findings 
demonstrated the curative effect of the extract, suggesting its potential therapeutic application 
in liver fibrosis and cirrhosis [25].
Another study investigated the effects of the C. sinensis peel extract when administered 
orally to rats at a concentration of 25 mg/kg and revealed its antidiabetic potential. The 
researchers administered a single dose of alloxan (120 mg/kg) to the rats, which triggered 
an increase in serum glucose levels and α‐amylase activity. Then, a group of the rats was 
administered C. sinensis, which normalized all the adverse changes induced by alloxan. This 
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reinforces the antidiabetic properties of the orange peel extract, which might be applied in 
the development of therapies for diabetes control [26].
In 2010, Faturi et al. demonstrated that the essential oil from C. sinensis had an anxiolytic effect 
when inhaled by rats. The animals were subjected to the elevated plus maze test, and the 
residence time of each rat in the open arms was measured. The possibility that the anxiolytic 
effect could result from any other inhaled aroma was discarded, since no anxiolytic activity 
was observed with Melaleuca alternifolia essential oil. The authors also reported that the ani‐
mals were not previously exposed to the essential oil of sweet orange or any solutions that 
could contain the essence [27].
In a clinical study conducted on patients waiting for dental care, a group of the patients 
inhaled sweet orange essential oil in the waiting room, a second group listened to music, and 
the third group, which was the control group, did not receive any intervention. The results 
showed that the patients who inhaled the essential oil were calmer and had lower anxiety 
levels than the patients of the other groups [28].
Results obtained by Goes et al. in 2012 demonstrated the anxiolytic effect of the C. sinensis 
essential oil on healthy individuals while performing an anxiogenic task. The anxiolytic 
activity was evidenced by the significant difference in the level of anxiety between the group 
exposed to C. sinensis and the control group, providing scientific support for the use of this 
essential oil as a tranquilizer in aromatherapy [29].
The results presented here support the use of C. sinensis as an aid to combat insomnia and 
anxiety. Research also indicates that the natural constituents of sweet orange can be used in 
the pharmaceutical industry, as natural cytotoxic agents, anthelmintics, antidiabetic agents, 
or for the treatment of liver cirrhosis.
2.3. Citrus bergamia
Citrus bergamia, commonly known as bergamot [30], is a plant belonging to family Rutaceae, 
subfamily Esperidea, and is defined as a hybrid between bitter orange (Citrus aurantium) 
and lemon (Citrus limon) [31]. The botanical and geographical origins of this plant are still 
unknown. The name “bergamot” seems to be derived from Berga, a Spanish city from which 
the plant was transported to Calabria in Southern Italy. C. bergamia is cultivated almost exclu‐
sively along the southern coast of Calabria; over 90% of its world production comes from 
this region. However, it is also cultivated to a lesser extent in other countries, such as Greece, 
Morocco, Iran, Ivory Coast, Argentina, and Brazil [32].
The fruit of C. bergamia is mainly used for the extraction of its essential oil, which is used 
in perfumes, drugs, cosmetics, food, and clothing [33]. Throughout the cultivation and the 
processing of C. bergamia, tons of wastes of low commercial value, but of great industrial 
potential, are generated. These wastes contain high levels of nutrients, pigments, and bioac‐
tive components with low toxicity [34].
There are evidences that C. bergamia contains antibacterial and antifungal active constituents, 
in addition to its anti‐inflammatory, antiproliferative, neuropsychopharmacological, neuro‐
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protective, and analgesic effects, [35] as well as its cardiovascular properties in rodents [32]. 
Bergamot juice, which is obtained from the endocarp after the extraction of the essential oil, 
was found to exhibit hypoglycemic and hypolipidemic activities, as well as anti‐inflammatory 
[36–38] and anticancer properties [39].
The anti‐infective properties of C. bergamia derivatives can be observed from the action of its 
essential oil against bacteria, mycetes, and larvae, and the action of its juice against Helicobacter 
pylori. Compounds derived from its fruit peel extract have antimicrobial properties. Studies 
report that its essential oil has antibacterial and antifungal activities against Campylobacter 
jejuni, Escherichia coli O157, Listeria monocytogenes, Bacillus cereus, Staphylococcus aureus, and 
dermatophytes. The essential oil of C. bergamia shows in vitro activity against Candida spe‐
cies, which suggests its potential application in the topical treatment of fungal infections by 
Candida. It also demonstrates in vitro activity against dermatophytes [40].
In addition, favorable results were obtained regarding its pharmacological properties in ner‐
vous system disorders. Sometimes, the essential oil from C. bergamia, usually extracted from 
the peel, is used in aromatherapy to relieve stress and anxiety [41].
In a study carried out on rats to investigate the anxiolytic activity of C. bergamia, the essential 
oil was administered to the rats at different concentrations and its effects were compared with 
those of diazepam. The results of this study indicated that C. bergamia showed an anxiolytic 
action, which was observed when the rats were subjected to the elevated plus maze and hole‐
board tests. The researchers observed a reduction in the activity of the hypothalamic‐pitu‐
itary‐adrenal axis, reducing corticosterone response to stress [42].
Clinical studies have also reported beneficial effects of C. bergamia essential oil in cardiac 
control, blood pressure reduction, and stress response management, in addition to its effect 
on the central nervous system [43]. Although the mechanisms by which the effects on the 
central nervous system are mediated have not yet been fully elucidated, it has been suggested 
that this action might be mediated by the release of amino acids that modulate the synaptic 
plasticity [32].
Some studies demonstrated that the essential oil from C. bergamia also shows anticancer activ‐
ity. For example, Berliocchi et al. demonstrated in vitro antiproliferative activity of C. bergamia 
essential oil against SH‐SY5Y human neuroblastoma cells. In this work, the lethal effect of 
C. bergamia was mediated by activating multiple pathways that lead to cell death by both 
necrosis and apoptosis [44]. Compounds derived from bergamot oil, such as limonene, mono‐
terpenes related to limonene, alcohol, and perillic acid, were also found to inhibit the prolif‐
eration of breast cancer cells, and to show chemopreventive and chemotherapeutic effects in 
models of mammary tumors [45].
However, the poor water solubility, weak stability, and limited bioavailability of essential 
oils have prevented their use in cancer therapy. Nevertheless, due to the favorable results 
regarding the anticancer action of the essential oil from C. bergamia, some attempts have been 
made to use bergamot in cancer therapy. For example, in 2013, Celia et al. developed lipo‐
somes of C. bergamia essential oil, which improved its water solubility and increased its in 
vitro anticancer activity against SH‐SY5Y human neuroblastoma cells [46].
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In order to elucidate the mechanisms by which the essential oil from C. bergamia has antican‐
cer activity, Russo R et al. conducted a study in 2013 to identify the components involved in 
the cell death process. The results of the study suggested an important role of the combined 
action of monoterpenes in the process of cell death [35].
Regarding the protective cardiovascular properties, Di Donna et al. established a rat model 
in 2014 to investigate the hypocholesterolemic effect of 3‐hydroxy‐3‐methyl‐glutaryl flava‐
nones enriched fraction (HMGF), extracted from C. bergamia fruits, in comparison with that 
of statin (simvastatin). Both HMGF and simvastatin reduced total cholesterol, triglycerides, 
very low density lipoproteins (VLDL), and low‐density lipoproteins (LDL). However, only 
HMGF caused an increase in high‐density lipoprotein (HDL). In addition, HMGF showed no 
genotoxic effects and was cytotoxic only at high concentrations. Thus, the authors concluded 
that daily supplementation of HMGF in the diet can be very effective against hypercholester‐
olemia, featuring the cardiovascular protective properties of bergamot [47].
Although all the pharmacological effects of C. bergamia indicate potential clinical applications 
in the future, only clinical studies investigating its anxiolytic effects in aromatherapy were 
published heretofore [32].
2.4. Citrus limon
The Latin name of lemon is C. limon (Linnaeus) N. Burman. It belongs to family Rutaceae, 
and it is sometimes called limoeiro or limoeiro‐azêdo [48]. It originated in Southeast Asia 
and is believed to have been introduced to Europe by Muslims across the Iberian Peninsula 
and Sicily [5]. Currently, Spain is considered the main producer country of this genus in the 
Mediterranean region. Lemon is considered the third most important species of the genus 
Citrus, as it contains many relevant natural chemical compounds, including citric acid, ascor‐
bic acid, minerals, and flavonoids [49].
Recently, some of the therapeutic properties of C. limon have been recognized in the literature. 
Studies have found that the use of lemon helps neutralize the acidity of the gastric environ‐
ment, by stimulating the production of potassium carbonate, indicating its protective effects 
on the gastric mucosa. It was also found to have analgesic, anti‐anemic, anti‐sclerotic, anti‐
pyretic, antiseptic, emollient, and moisturizer properties. The recognized actions of lemon 
cellulose are that it is anti‐diarrheal, diuretic, intestinal mucosa protector, local hemostatic, 
vascular stimulant and protector, and vitamin [5].
Production networks of lemon generate large amounts of wastes and by‐products, which are 
an important source of bioactive compounds with potential applications in animal feeding, 
processed foods, and health care [49]. Although its health benefits are always attributed to its 
vitamin C content, recently, it has been found that flavonoids also play an important role [48]. 
Some authors suggest that flavonoids present in lemon have different biological functions, 
including antioxidant, anti‐inflammatory, antiallergic, antiviral, antiproliferative, antimuta‐
genic, and anticancer activities [48].
Hesperidin, which is the main flavonoid in C. limon, influences the vascular permeability, 
increases the capillary resistance, and has analgesic and anti‐inflammatory properties [49]. It 
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is also an effective antioxidant, since it is capable of scavenging free radicals that are involved 
in cancer. Some studies have shown that flavonoids present in lemon juice also have hypo‐
cholesterolemic properties [50].
Trovato et al. conducted a study on rats in 1996 and found that C. limon had a significant effect 
on the levels of cholesterol and triglycerides, suggesting that the prolonged consumption of 
its juice might offer significant protection from hypercholesterolemia [51].
Another study investigated the protective effect of the essential oil from C. limon against acute 
hepatic and renal damage induced by a high dose of aspirin in Wistar albino rats. The data 
obtained in this study demonstrated that the treatment with C. limon protected the liver and 
kidney from damages induced by aspirin [52].
Regarding the pharmacological effects on the central nervous system, a recent study con‐
ducted by Khan and Riaz evaluated the effects of lemon on the behavior of rats, using three 
different doses (0.2, 0.4, and 0.6 ml/kg), considered low, moderate, and high doses, respec‐
tively. The anxiolytic and antidepressant activities were evaluated twice, for 15 days, using 
the open field, elevated plus maze, and forced swimming tests. In the open field test, C. limon 
revealed an increase in the distance traveled, the number of central entries, and the number 
of rearing at moderate dose, while in the elevated plus maze, the number of open arm entries 
was found to be increased. Whereas in the forced swimming test, there was a decrease in 
duration of immobility and an increase in the duration of climbing. Thus, results suggest that 
C. limon at moderate dose has an anxiolytic effect [53].
It has been noted that disorders such as anxiety and depression can be managed through 
healthier variations in dietary patterns, since there is evidence that a diet rich in antioxidants 
and vitamins reduces these symptoms. Accordingly, a study was performed in order to evalu‐
ate the behavioral effects of C. limon and Punica granatum in rats. In this study, two com‐
binations of doses were used: 0.4 + 5 ml/kg and 0.2 + 8 ml/kg of C. limon and P. granatum, 
respectively. As in the previous study, the antidepressant and anxiolytic effects were evalu‐
ated twice, for 15 days, using forced swimming, open field, and elevated plus maze tests. In 
the open field test, the use of C. limon and P. granatum showed an increase in the distance trav‐
eled and the number of central entries at the dose combination of 0.4 + 5 ml/kg. In the elevated 
plus maze test, the number of entries was increased at the highest dose combination (0.2 + 8 
ml/kg). In the forced swimming test, there was a decrease in the immobility duration and an 
increase in the climbing duration at both dose combinations: 0.4 + 5 ml/kg and 0.2 + 8 ml/kg 
C. limon and P. granatum, respectively. Based on these results, the authors suggested that C. 
limon and P. granatum, at a combination of 0.4 + 5 ml/kg, show anxiolytic and antidepressant 
effects [54].
In another study conducted by Riaz et al. in 2014, the effect of C. limon and pomegranate 
juice on rats’ memory was evaluated. It is known that memory is greatly influenced by factors 
such as diet, stress, and sleep quality. The results of this study indicated that C. limon contains 
essential phytochemicals and nutrients that improve the memory, particularly the short‐term 
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memory. They also concluded that flavonoids in these juices could be responsible for this 
effect [55].
Hesperidin extracted from C. limon was found to play an important vasodilator action. In 
2016, Dobias et al. evaluated the effect of hesperidin on vascular responses in normotensive 
and hypertensive rats. Fifteen‐week‐old healthy Wistar rats and spontaneously hypertensive 
(SHR) rats were randomly assigned to receive either hesperidin (50 mg/kg/day) or a corre‐
sponding volume of water orally for 4 weeks. The vascular responses of isolated femoral arter‐
ies were studied using a myograph under control conditions and during the NO‐synthase 
inhibition. Although hesperidin had no effects on blood pressure, it significantly improved 
endothelium‐dependent vasodilation in Wistar and SHR rats. The contraction responses were 
increased in all the groups to a similar extent, but the relaxing responses were significantly 
attenuated in the SHR group only. The inhibition of the potassium channels (Kv) significantly 
reduced the endothelium‐dependent vasodilator response only in SHR rats administered 
hesperidin. This indicates that hesperidin can improve endothelium‐dependent vasodilation 
during hypertension [56].
Regarding the anti‐inflammatory activities described for C. limon, in 2016, Amorim et al. con‐
ducted a study to confirm the hypothesis that essential oil (EO) from C. limon, C. latifolia, C. 
aurantifolia, and C. limonia have antinociceptive effects. Thus, they were tested each one on 
the formalin‐induced licking behavior. This model is a widely used pain model in evaluat‐
ing antinociceptive and anti‐inflammatory drugs. The results of this study suggest that EO 
from C. limon, C. aurantifolia, and C. limonia have an anti‐inflammatory effect because they 
reduced the second phase response to formalin. This may occur through a reduction in 
inflammatory mediator liberation in mice paws or a direct action on one or more mediator 
receptors [57].
Since C. limon is widely used in traditional medications in India and China, we sought to 
explore the importance of flavonoids that are abundant in citrus fruits on platelet function. 
Nobiletin is a highly abundant flavonoid present in these and has been shown to reduce 
the adhesive properties of platelets. In 2015, Vaiyapuri et al. conducted a study to verify 
the pharmacological effects of a polymethoxy flavonoid, nobiletin, in the modulation of 
platelet function. Nobiletin was shown suppress a range of well‐established activatory 
mechanisms, including platelet aggregation, granule secretion, integrin modulation, cal‐
cium mobilization, and thrombus formation. This study provided insight into the underly‐
ing molecular mechanisms through which nobiletin modulates hemostasis and thrombus 
formation. Therefore, nobiletin may represent a potential antithrombotic agent of dietary 
origins [58].
In conclusion, C. limon presents numerous curative properties, and thus it has been widely 
used as a traditional medicine for the treatment of various diseases [52]. However, more stud‐
ies still need to be conducted in order for its application in clinical practice to be established 
and disseminated [59].
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3. Conclusion
Citrus species are well known and have been commonly used by populations for hundreds of 
years for various purposes. This knowledge of their therapeutic potential has led to several 
studies that proved the pharmacological effects of the above‐mentioned species (Table 1). The 
effect of Citrus species on the central nervous system was highlighted as the study objective in 
most of the publications. However, research has advanced in seeking other pharmacological 
actions, especially of isolated constituents of the species.
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Citrus species Pharmacological action
Citrus aurantium L. Gastrointestinal stimulant and general tonic.
Treatment of central nervous system disorders like 
insomnia, anxiety, and hysteria.
Relieve stomach cramps and constipation, combat stomach 
acidity.
Hypoglycemic effect.
Anti‐inflammatory.
Anxiolytic effect.
Citrus sinensis Sedative action.
Anthelmintic properties.
Treatment of liver cirrhosis.
Antidiabetic properties.
Anxiolytic effect.
Citrus bergamia Antibacterial. Antifungal. Anti‐inflammatory. 
Analgesic. Antiproliferative and anticancer properties. 
Neuropsychopharmacological. Neuroprotective.
Anxiolytic activity.
Hypoglycemic and hypolipidemic activities.
Citrus limon Analgesic. Anti‐anemic. Anti‐sclerotic. Antipyretic. 
Antiseptic.
Emollient and moisturizer properties.
Anti‐diarrheal. Diuretic. Intestinal mucosa protector. Local 
hemostatic.
Vascular stimulant and protector.
Antioxidant. Antiallergic. Antiviral. Anti‐inflammatory. 
Antiproliferative, antimutagenic, and anticancer activities.
Table 1. Pharmacological action of different citrus species (studies in vitro and in vivo).
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